Health
Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India – Medical Xpress
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across Indiaone of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
General13 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
General18 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News17 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Business16 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?